Dosimetric characteristics of the new RadioCoil™ 103Pd wire line source for use in permanent brachytherapy implants

Medical Physics

Volumn 31, Issue 11, 2004, Pages 3095-3105

  Meigooni, A S ^a   Zhang, H ^a   Clark, J R ^a   Rachabatthula, V ^a   Koona, R A ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

103Pd; Brachytherapy; Dosimetry; Linear source; Prostate

Indexed keywords

DOSIMETRY; LIQUIDS; LITHIUM COMPOUNDS; MONTE CARLO METHODS; ONCOLOGY; RADIOTHERAPY; RATE CONSTANTS; UROLOGY;

BRACHYTHERAPY; CLINICAL APPLICATION; LINEAR SOURCE; MONTE CARLO CALCULATION; PROSTATE; THERMOLUMINESCENT DOSIMETERS; TWO DIMENSIONAL (2 D); ^103PD;

FLUORINE COMPOUNDS;

ANISOTROPY; ARTICLE; ENERGY RESOURCE; IMPLANT; MONTE CARLO METHOD; NEUTRON DOSIMETRY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION BEAM; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING;

EID: 9244261598     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1809851     Document Type: Article

References (30)

1. 103Pd brachytherapy source," Med. Phys. 28, 2568-2575 (2001).
2. K. J. Russel and J. C. Blasko, "Recent advances in interstitial brachytherapy for localized prostate cancer," Probl. Urol. 7, 260-278 (1993).
3. D. Nori, "Conformal brachytherapy of prostate cancer: an effective outpatient treatment," Cancer Res. 1, 124-126 (1992).
4. M. S. Porrazzo, B. S. Hilaris, C. R. Moorthy, A. E. Tchelebi, C. A. Mastoras, L. L. Shih, L. Stabile, and N. Salvaras, "Permanent interstitial implantation using palladium-103: The New York Medical College preliminary experience," Int. J. Radiat. Oncol., Biol., Phys. 23, 1033-1036 (1992).
5. 125I implantation for stage T1/T2 prostate carcinoma," J. Urol. (Baltimore) 154, 1096-1099 (1995).
6. H. Sommerkamp, M. Ruppercht, and M. Wannenmacher, "Seed Loss in interstitial radiotherapy of prostatic carcinoma with I-125," Int. J. Radiat. Oncol., Biol., Phys. 14, 389-392 (1988).
7. J. Willins and K. Wallner, "Time-dependent changes in CT-based dosimetry for I-125 prostate brachytherapy," Radiat. Oncol. Invest. 6, 157-160 (1998).
8. G. S. Merrick, W. M. Butler, A. T. Dorsey, and H. L. Walbert, "The influence of timing on the dosimetric analysis of transperineal ultrasound guided prostatic conformal brachytherapy," Radiat. Oncol. Invest. 6, 182-190 (1998).
9. 125I implantation," Int. J. Radiat. Oncol., Biol., Phys. 21, 537-547 (1991).
10. P. P. Kumar and R. R. Good, "Vicryl carrier for I-125 seeds: Percutaneous transperineal insertion," Radiology 159, 276 (1986).
11. W. M. Butler and G. S. Merrick, "I-125 Rapid Strand™ loading technique," Radiat. Oncol. Invest. 4, 48-49 (1996).
12. Y. Yu, L. L. Anderson, Z. Li, D. E. Mellenberg, R. Nath, M. C. Schell, F. M. Waterman, and A. Wu, "Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64," Med. Phys. 26, 2054-2076 (1999).
13. G. S. Merrick, W. M. Butler, A. T. Dorsey, J. H. Lief, and M. L. Benson, "Seed fixity in the prostate/periprostatic region following brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 46, 215-220 (2000).
14. E. M. Tapen, J. C. Blasko, P. D. Grimm, H. Radge, L. Ray, S. Cliford, J. Sylvester, and T. Griffin, "Reduction of radioactive seed embolization to lung following prostate brachytherapy," Int. J. Radiat. Oncol., Biol., Phys. 42, 1063-1067 (1998).
15. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43," Med. Phys. 22, 209-234 (1995).
16. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. Saiful Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, "Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations," Med. Phys. 31, 633-674 (2004).
17. 125I brachytherapy source," Med. Phys. 27, 2168-2173 (2000).
18. A. S. Meigooni, V. Mishra, H. Panth, and J. F. Williamson, "Instrumentation and dosimeter-size artifacts in quantitative thermoluminescent dosimetry of low-dose fields," Med. Phys. 22, 555-561 (1995).
19. P. J. Muench, A. S. Meigooni, R. Nath, and W. L. McLaughlin, "Photon energy dependence of the sensitivity of radiochromic film and comparison with silver halide film and LiF TLDs used for brachytherapy dosimetry," Med. Phys. 18, 769-775 (1991).
20. J. F. Williamson, "Monte Carlo simulation of photon transport phenomena" in Monte Carlo Simulation in the Radiological Science, edited by R. L. Morin (CRC, Boca Raton, FL, 1988), pp. 53-102.
21. D. K. Trubey, "HUGI VI notes documentation for the DLC-146 code package," Radiation Safety Information Computational Center, 1989.
22. J. H. Hubbell and S. M. Seltzer, "Tables of x-ray mass attenuation coefficients and mass energy - absorption coefficients 1 keV to 20 MeV for elements Z=1 to 92 and 48 additional substances of dosimetric interest" NISTIR, 5632, 1995.
23. National Council on Radiation Protection and Measurements, Report No. 58: "A handbook of radioactivity measurements procedures," Bethesda, MD, 1985.
24. 103Pd brachytherapy seeds," J. Res. Natl. Inst. Stand. Technol. 108, 337-358 (2003).
25. 103Pd seeds with air kerma strength calibration based upon a primary national standard," Med. Phys. 27, 655-658 (2000).
26. 103Pd interstitial brachytherapy source," Med. Phys. 27, 643-654 (2000).
27. 103Pd brachytherapy source," Med. Phys. 26, 2465-2470 (1999).
28. 103Palladium brachytherapy source," Med. Phys. 27, 1093-1100 (2000).
29. A. S. Meigooni, H. Zhang, C. Perry, S. A. Dini, and R. A. Koona, "Theoretical and experimental determination of dosimetric characteristics for brachySeed Pd-103 Model Pd-1 source," Appl. Radiat. Isot. 58, 533-541 (2003).
30. 103Pd sources," Med. Phys. 25, 2271-2278 (1998).